These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 24083636)

  • 1. Effects of testosterone treatment on body composition in males with testosterone deficiency syndrome.
    Rodriguez-Tolrà J; Torremadé Barreda J; del Rio L; di Gregorio S; Franco Miranda E
    Aging Male; 2013 Dec; 16(4):184-90. PubMed ID: 24083636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of testosterone treatment on bone mineral density in men with testosterone deficiency syndrome.
    Rodriguez-Tolrà J; Torremadé J; di Gregorio S; Del Rio L; Franco E
    Andrology; 2013 Jul; 1(4):570-5. PubMed ID: 23686863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of oral testosterone undecanoate therapy on bone mineral density and body composition in 322 aging men with symptomatic testosterone deficiency: a 1-year, randomized, placebo-controlled, dose-ranging study.
    Bouloux PM; Legros JJ; Elbers JM; Geurts TB; Kaspers MJ; Meehan AG; Meuleman EJ;
    Aging Male; 2013 Jun; 16(2):38-47. PubMed ID: 23581697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled trial on the effect of long-acting testosterone treatment as assessed by the Aging Male Symptoms scale.
    Ho CC; Tong SF; Low WY; Ng CJ; Khoo EM; Lee VK; Zainuddin ZM; Tan HM
    BJU Int; 2012 Jul; 110(2):260-5. PubMed ID: 22093057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind, placebo-controlled trial of testosterone gel on body composition and health-related quality-of-life in men with hypogonadal to low-normal levels of serum testosterone and symptoms of androgen deficiency over 6 months with 12 months open-label follow-up.
    Behre HM; Tammela TL; Arver S; Tolrá JR; Bonifacio V; Lamche M; Kelly J; Hiemeyer F; ; Giltay EJ; Gooren LJ
    Aging Male; 2012 Dec; 15(4):198-207. PubMed ID: 22834649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-intermediate dose testosterone replacement therapy by different pharmaceutical preparations improves frailty score in elderly hypogonadal hyperglycaemic patients.
    Strollo F; Strollo G; Morè M; Magni P; Macchi C; Masini MA; Carucci I; Celotti F; Ruscica M; Gentile S
    Aging Male; 2013 Jun; 16(2):33-7. PubMed ID: 23517433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-year follow-up of androgen treatment in hypogonadal men: preliminary report with testosterone gel.
    Swerdloff RS; Wang C
    Aging Male; 2003 Sep; 6(3):207-11. PubMed ID: 14628501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intramuscular testosterone undecanoate on body composition and bone mineral density in female-to-male transsexuals.
    Mueller A; Haeberle L; Zollver H; Claassen T; Kronawitter D; Oppelt PG; Cupisti S; Beckmann MW; Dittrich R
    J Sex Med; 2010 Sep; 7(9):3190-8. PubMed ID: 20584125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short term testosterone replacement therapy improves libido and body composition.
    Andrade ES; Clapauch R; Buksman S
    Arq Bras Endocrinol Metabol; 2009 Nov; 53(8):996-1004. PubMed ID: 20126853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral anabolic steroid treatment, but not parenteral androgen treatment, decreases abdominal fat in obese, older men.
    Lovejoy JC; Bray GA; Greeson CS; Klemperer M; Morris J; Partington C; Tulley R
    Int J Obes Relat Metab Disord; 1995 Sep; 19(9):614-24. PubMed ID: 8574271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double-blind placebo-controlled study of testosterone patch therapy on bone turnover in men with borderline hypogonadism.
    Merza Z; Blumsohn A; Mah PM; Meads DM; McKenna SP; Wylie K; Eastell R; Wu F; Ross RJ
    Int J Androl; 2006 Jun; 29(3):381-91. PubMed ID: 16390499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral testosterone replacement in symptomatic late-onset hypogonadism: effects on rating scales and general safety in a randomized, placebo-controlled study.
    Legros JJ; Meuleman EJ; Elbers JM; Geurts TB; Kaspers MJ; Bouloux PM;
    Eur J Endocrinol; 2009 May; 160(5):821-31. PubMed ID: 19211706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of baseline serum testosterone on changes in body composition in response to testosterone therapy.
    Di Sante S; Conners WP; Morgentaler A
    J Sex Med; 2012 Feb; 9(2):585-93. PubMed ID: 22145684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone replacement therapy does not promote priapism in hypogonadal men with sickle cell disease: 12-month safety report.
    Morrison BF; Reid M; Madden W; Burnett AL
    Andrology; 2013 Jul; 1(4):576-82. PubMed ID: 23606509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen deficiency and hormone-replacement therapy.
    Isidori AM; Greco EA; Aversa A
    BJU Int; 2005 Aug; 96(2):212-6. PubMed ID: 16001962
    [No Abstract]   [Full Text] [Related]  

  • 16. Change in cytokine levels after administration of saikokaryuukotsuboreito or testosterone in patients with symptoms of late-onset hypogonadism.
    Tsujimura A; Miyagawa Y; Okuda H; Yamamoto K; Fukuhara S; Nakayama J; Takao T; Nonomura N; Okuyama A
    Aging Male; 2011 Mar; 14(1):76-81. PubMed ID: 20712429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate-specific antigen (PSA) concentrations in hypogonadal men during 6 years of transdermal testosterone treatment.
    Raynaud JP; Gardette J; Rollet J; Legros JJ
    BJU Int; 2013 May; 111(6):880-90. PubMed ID: 23294726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estradiol levels in men with congenital hypogonadotropic hypogonadism and the effects of different modalities of hormonal treatment.
    Trabado S; Maione L; Salenave S; Baron S; Galland F; Bry-Gauillard H; Guiochon-Mantel A; Chanson P; Pitteloud N; Sinisi AA; Brailly-Tabard S; Young J
    Fertil Steril; 2011 Jun; 95(7):2324-9, 2329.e1-3. PubMed ID: 21536274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of 12 month oral testosterone on testosterone deficiency symptoms in symptomatic elderly males with low-normal gonadal status.
    Haren M; Chapman I; Coates P; Morley J; Wittert G
    Age Ageing; 2005 Mar; 34(2):125-30. PubMed ID: 15596419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience with Andriol Testocaps--the first Austrian surveillance study on the treatment of late-onset hypogonadism.
    Jungwirth A; Plas E; Geurts P
    Aging Male; 2007 Dec; 10(4):183-7. PubMed ID: 18033627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.